Acute chest pain (ACP) is a common symptom that often leads to hospital admission. It is a challenge for healthcare professionals due to its broad differential diagnosis, ranging from benign conditions to life-threatening diseases such as acute coronary syndrome (ACS).
Each encounter with a patient presenting ACP should begin with a thorough history and physical examination. The patient's age, sex, risk factors for cardiovascular disease, and the characteristics of the pain should guide the initial assessment. A detailed history can help distinguish cardiac from non-cardiac causes.
Electrocardiogram (ECG) is the first-line diagnostic test in ACP. It can identify ST-segment elevation myocardial infarction (STEMI), which requires immediate reperfusion therapy. In non-diagnostic ECGs, high-sensitivity cardiac troponin (hs-cTn) assays are critical for the early detection of non-ST elevation ACS.
Risk stratification is crucial in ACP. Several risk scores, such as the GRACE and TIMI scores, can predict the likelihood of adverse outcomes in ACS. These scores can guide the decision for invasive management. For low-risk patients, coronary CT angiography can rule out significant coronary artery disease.
Management of ACP depends on the underlying cause. In ACS, early reperfusion therapy in STEMI or optimal medical therapy in non-ST elevation ACS is recommended. Non-cardiac causes of ACP should be managed accordingly. It is essential to reassess the patient's response to treatment and adjust the management plan as necessary.
In conclusion, the approach to ACP involves a systematic evaluation, appropriate diagnostic testing, risk stratification, and tailored management strategies. A high index of suspicion and a comprehensive understanding of the various causes of ACP are crucial for healthcare professionals to provide the best patient care.
1.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Weight loss trial reports success for breast cancer patients at one year mark
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
3.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Epigenetic Subtyping of Complex Hematologic Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Updates on the First Line Management of ALK+ NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation